Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
US6569853B1 · kind B1 · utility
48Cited by
2References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2000 |
| Grant date | May 27, 2003 |
| Priority date | — |
| Expiry date | Jun 6, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features a method for treating a patient having a cancer or other neoplasm, by administering to the patient (i) chlorpromazine or a metabolite or analog thereof; and (ii) pentamidine or a metabolite or analog thereof simultaneously or within 14 days of each other in amounts sufficient to inhibit the growth of the neoplasm.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.